BioSpace
Small Study of GSK Rectal Cancer Drug Yields "Unheard of" Results | BioSpace
In a small study of 14 rectal cancer patients, researchers at Memorial Sloan Kettering Cancer Center published results where 100% of the 12 patients who completed treatment went into remission.